This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rossi, R. Articles by Di Simplicio, P. Search for Related Content PubMed PubMed Citation Articles by Rossi, R. Articles by Di Simplicio, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cholesterol High Risk Pregnancy

(Circulation Research. 2001;89:e47.)
© 2001 American Heart Association, Inc.

Letters to the Editor

Physiological Levels of S-Nitrosothiols in Human Plasma

Ranieri Rossi, Daniela Giustarini, Aldo Milzani, Roberto Colombo, Isabella Dalle-Donne, Paolo Di Simplicio

Department of Neuroscience, Pharmacology Unit, University of Siena, Siena, Italy, ranieri@unisi.it
Department of Biology, University of Milan, Milan, Italy
Department of Neuroscience, Pharmacology Unit, University of Siena, Siena, Italy

To the Editor:

The hypothesis that endothelial-derived relaxing factor (EDRF) is nitric oxide (NO) has stimulated a wealth of research into the significance of this novel, intriguing molecule. Given its short life, many forms of storage and targeting have been postulated: among these, a pool of derivatives of NO (RSNOs) covalently bound to SH groups of proteins and low molecular weight thiols (eg, glutathione) has been identified in various biological systems. The importance of RSNOs results from the very similar biological actions exhibited by both NO and RSNOs in vivo as well as in vitro.

S-nitroso derivatives of GSH, cysteine, hemoglobin, BSA, and many other protein or nonprotein thiols are potent, fast-acting vasodilators, as well as strong inhibitors of platelet aggregation, like NO itself. Moreover, several nitrosovasodilators, such as nitrosoglycerin, have been reported to function through the formation of S-nitrosothiol intermediates.

S-nitrosothiols in biological samples have been measured by a wide spectrum of different techniques. However, in our opinion, most of these techniques are not devoid of artifacts, and the investigation of endogenous S-nitrosothiol levels, as stated by Neil Hogg, "is hampered by methodological concerns" (page 1482).¹ For example, the original report of 7 µmol/L for S-nitrosothiols² in human plasma has been more recently downgraded to very low levels.^3–5

A recent study by Tyurin et al⁶ showed that the S-nitrosoprotein level (mostly S-nitroso albumin) was 9.2±1.6 µmol/L in normal human plasma and 11.1±2.9 and 9.4±1.5 µmol/L in pregnant and preeclamptic pregnant women, respectively. In particular, these . . . [Full Text of this Article]

This article has been cited by other articles:

				S. C. Rogers, A. Khalatbari, P. W. Gapper, M. P. Frenneaux, and P. E. James Detection of Human Red Blood Cell-bound Nitric Oxide J. Biol. Chem., July 22, 2005; 280(29): 26720 - 26728. [Abstract] [Full Text] [PDF]

				X. Wang, J. E. Tanus-Santos, C. D. Reiter, A. Dejam, S. Shiva, R. D. Smith, N. Hogg, and M. T. Gladwin Biological activity of nitric oxide in the plasmatic compartment PNAS, August 3, 2004; 101(31): 11477 - 11482. [Abstract] [Full Text] [PDF]

				M. T. Gladwin, X. Wang, C. D. Reiter, B. K. Yang, E. X. Vivas, C. Bonaventura, and A. N. Schechter S-Nitrosohemoglobin Is Unstable in the Reductive Erythrocyte Environment and Lacks O2/NO-linked Allosteric Function J. Biol. Chem., July 26, 2002; 277(31): 27818 - 27828. [Abstract] [Full Text] [PDF]